Resected Pancreatic Cancer With N2 Node Involvement Is Refractory to Gemcitabine-Based Adjuvant Chemotherapy

Lymphatic metastasis is a major determinant of the outcome of resected pancreatic cancer. Gemcitabine-based adjuvant chemotherapy can improve the outcome of resected pancreatic cancer. However, the efficacy of gemcitabine against pancreatic cancer stratified by nodal involvement is unclear. In this...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer Control
Päätekijät: Liu, Chen, Cheng, He, Jin, Kaizhou, Fan, Zhiyao, Gong, Yitao, Qian, Yunzhen, Deng, Shengming, Huang, Qiuyi, Ni, Quanxing, Yu, Xianjun, Luo, Guopei
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: SAGE Publications 2020
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7153189/
https://ncbi.nlm.nih.gov/pubmed/32268796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1073274820915947
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia